Miikka Vikkula2d ago
An exciting ISSVA 2026 in Philly: 100 oral presentations on vascular anomalies, numerous posters, and intense discussions during sessions, breaks, poster walks and sponsored sessions. A great keynote by Taija_Makinen. A touching tribute to the late founder of ISSVA, John Mulliken, underscoring his message for curiosity, accuracy, compassion, and collaboration. #VASCERN and #VASCA also present. Looking forward to ISSVA Debates Dublin 5-7 May 2027. #VASCAPA #RADIORG #HEVAS #CMTc #uclouvain #ISSVA
Miikka VikkulaMay 12

An exciting first day at the #iDR26 meeting in Brussels on drug #repurposing.

Academics, company representatives, funders, policy makers, patients and others, all gathered to discuss how to help #repurpose #medicines for the many #diseases still with unmet medical needs, including #vascular #anomalies.

#IDR26 #VASCERN #VASCAPA #RADIORG #HEVAS #CMTC #Eurordis #WELRI #de Duve Institute #uclouvain #FNRS #ISSVA #REVAMP #Leducq

Miikka VikkulaApr 30
Nos recherches sur le lymphœdème et la découverte d'un nouveau gène TIE1 muté chez certains patients atteints de cette maladie viennent d'être vulgarisées par La Loupe, un média belge qui rend la science accessible à tous. L'article est à lire ici : https://la-loupe.be/fr/articles/tie1-lymphedeme-vikkula #lymphedema #lymphe #hevas #VASCERN #deDuveInstitute #VASCAPA #lymphödem #uclouvain #Welbio #FNRS #uclouvain
Le gène TIE1 et les lymphœdèmes inexpliqués — Découverte UCLouvain — La Loupe

Des mutations du gène TIE1 causent des lymphœdèmes primaires tardifs. Étude sur 755 patients par le Pr. Vikkula — UCLouvain, JCI 2024.

La Loupe
Miikka VikkulaApr 28
Fabian’s great work on Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral venous malformations is now published. Elsevier gives access 50 days' free access to the article, until June 13, 2026. The link to the final version of the article on ScienceDirect, which you are welcome to read or download. No sign up.https://authors.elsevier.com/c/1m~tx,GNpk4tED
#VASCERN #VASCAPA #RADIORG #HEVAS #CMTC #Eurordis #Welbio #deDuveInstitute #uclouvain #FNRS #ISSVA
Miikka VikkulaApr 26
What a beautiful, heartfelt day of remembrance in honour of Dr. John B. Mulliken. Colleagues, patients, and friends came together to share their treasured memories of our dearly loved JBM. In tribute, Harvard Medical School lowered its flag at the Medical Quad to half-mast, a touching gesture reflecting the profound impact he had on so many lives.
#VASCERN #VASCAPA #RADIORG #HEVAS #CMTC #Eurordis #Welbio #de Duve Institute #uclouvain #FNRS
Miikka VikkulaApr 12
An interesting session on #vascular anomalies at the Society of #Interventional #radiology (#SIR) meeting in Toronto. Met new enthusiastic younger colleagues! #VASCAPA #CMTC #HEVAS #VASCERN
Miikka VikkulaMar 18
Our latest review, 'Current and Emerging Pharmacotherapies for Vascular Malformations', is online. First 50 can download the PDF for free via the link. Thank you, Emmanuel Seront, for putting it together! #VASCAPA #HEVAS #CMTC #VASCERN #RADIOORG #EURORDIS #EVBO #WELRI
https://www.tandfonline.com/eprint/QGPRVVUI8GUT6FQEJFQI/full?target=10.1080/17512433.2026.2641807
Miikka VikkulaMar 18

What a great #VASCERN-VASCA meeting. Thank you Roberta, Thi-Mai et Treasure for the organisation. And all those having presented the steps made forward in the various task forces. Looking forward to the follow-up of all the action points. #vascapa #hevas #cmtc #vascern #radiorg #eurordis

https://www.facebook.com/100069557370933/videos/pcb.1250340800627821/27316982817890243

VASCERN: The ERN on rare multisystemic vascular diseases on Reels

Miikka VikkulaFeb 24
It was a great annual #Crick #Rare Disease Conference 2026. Learned so much new, made novel contacts, and of course, discussed #precision #therapies for #vascular, and more specifically, #lymphatic anomalies. Organised by @Veronica K. #VASCERN #vascapa #hevas #eurordis #CMTC
Miikka VikkulaFeb 11
The VAS European Book on Angiology/Vascular Medicine (ISBN: 978-3-031-82232-2) is now published accessible in print and online ! #VASCAPA #HEVAS #CMTC #VASCERN #EURORDIS